Visit from our undergrad students at Utah Asia Campus

Today, my lab had the pleasure of hosting a group of enthusiastic students visiting from Utah Asia Campus. It was an inspiring experience to share our research with such a bright and inquisitive audience. One particularly exciting aspect of today’s visit was seeing that the majority of the students were women, all passionate about engineering. Their insightful questions reminded me of the global impact of collaboration and the importance of fostering cross-cultural exchanges in the field of education and research. A big thank you to everyone who made this visit possible.


Our lab awarded an Innovation in Cancer Engineering Grant!

The diagnosis of acute myeloid leukemia,Β  the most common leukemia in adult patients with only about 30% long term survivors, and evaluation of response to therapy are done using bone marrow aspirates and biopsies. These are invasive procedures with potential serious complications. The goal of this project is to test non-invasive, painless bioimpedance technology to serve as an adjunctive and convenient biomarker to standard bone marrow biopsies.

Nate receives 2024 NSF Graduate Research Fellowship!

πŸŽ‰ Exciting news! I am thrilled to announce that Nate has been granted the prestigious National Science Foundation (NSF) Graduate Research Fellowship! Collaborating with MD Anderson Cancer Center, his research will revolutionize the way we provide care to oropharyngeal cancer survivors. It’s a great honor to serve as his mentor, and I couldn’t be prouder of his remarkable achievements!

New NIH grant will answer whether wearables can improve health in LGBTQ + individuals

Did you know that πŸ³οΈβ€πŸŒˆ sexual and gender minorities (sometimes denoted LGBTQ+) have disproportionately high rates of depression, suicidal ideation, substance use, and physical health problems? Our new NIH grant will answer whether wearables can improve health disparities in LGBTQ + individuals during real-time social safety experiences in public settings by reducing their chronic threat-vigilance stress!

New grant from the American Cancer Society

Non-melanoma skin cancers are the most common cancers in the U.S. and their incidence is increasing. Electrical impedance dermography (EID) is a newer non-invasive, quantitative and objective tool sensitive to detect alterations in the electrical properties of skin cancers. The overarching hypothesis of this proposal is that EID can be used to distinguish cancer subtypes that cannot be appreciated clinically.